drugset / Trial / NCT02228928

Study of Capsaicin Patch for the Management of Peripheral Neuropathic Pain

NCT02228928

Phase 1/2 Completed 60 enrolled Samyang Biopharmaceuticals Corporation
RandomizedParallel-groupDouble-blindTreatment

Summary

The efficacy and safety of the low concentration \[0.65% (50 µg/cm2) and 1.25% (100 µg/cm2)\] capsaicin patches and compared them to conventional 0.075% capsaicin cream and placebo patch in patients suffering from peripheral neuropathy

Timeline

Start
2009-02
Primary completion
2011-05
Completion
2011-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Capsaicin Small molecule 0.075 % Topical
Subject Capsaicin Small molecule 0.625 % Topical
Subject Capsaicin Small molecule 1.25 % Topical